on MEDIAN TECHNOLOGIES (EPA:ALMDT)
Median Technologies: Presentation of eyonis™ LCS at ECR 2025
On February 24, 2025, Median Technologies announced its participation at the European Congress of Radiology (ECR) in Vienna, to present its innovative AI-based medical software, eyonis™ LCS. This software is designed to improve lung cancer screening. Median will be present from February 26 to March 1.
The eyonis™ LCS software recently successfully completed clinical validation, meeting the primary endpoints of the REALITY and RELIVE studies. These results pave the way for marketing applications in the United States and Europe expected in Q2 2025. Median COO Thomas Bonnefont highlights that these advances could improve oncology diagnostics.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MEDIAN TECHNOLOGIES news